Medicine and Dentistry
Patient
100%
Evaluation Study
100%
Chronic Myelogenous Leukemia
100%
Imatinib
100%
Combination Therapy
85%
Quantitative Reverse Transcription Polymerase Chain Reaction
28%
Therapeutic Procedure
14%
Drug
14%
Chemotherapeutic Agent
14%
Hospital
14%
Protein Tyrosine Kinase
14%
Examination
14%
Side Effect
14%
Clinical Examination
14%
Blood Smear
14%
Tyrosine-Kinase Inhibitor
14%
INIS
patients
100%
evaluation
100%
myeloid leukemia
100%
therapy
75%
kinases
25%
tyrosine
25%
polymerase chain reaction
25%
levels
12%
hospitals
12%
colleges
12%
drugs
12%
blood
12%
side effects
12%
values
12%
monitors
12%
Pharmacology, Toxicology and Pharmaceutical Science